Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

32.38 UNCHANGED
Streaming Delayed Price Updated: 12:11 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022 ↗
 
Via Benzinga
Analyst Ratings for Immunocore Hldgs ↗
 
Via Benzinga
Where Immunocore Hldgs Stands With Analysts ↗
 
Via Benzinga
7 Analysts Have This to Say About Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday ↗
 
Via Benzinga
News headline image
Where Immunocore Hldgs Stands With Analysts ↗
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Immunocore Hldgs ↗
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter: 
Via Benzinga
News headline image
5 Analysts Have This to Say About Immunocore Hldgs ↗
Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 50 stocks hit new 52-week highs. 
Via Benzinga
News headline image
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade ↗
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust. 
Via Benzinga
News headline image
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Immunocore Shares Fall After Early Solid Cancer Trial Data Of TCR Therapy ↗
 
Via Benzinga
News headline image
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
News headline image
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday. 
Via Benzinga
News headline image
Stocks Extend Gains, Weekly Wins In Sight ↗
Stocks are extending this morning's gains, with the Dow Jones Industrial Average last seen up 317 points. 
Via Talk Markets
News headline image
Analyzing Immunocore Hldgs's Short Interest ↗
Immunocore Hldgs's (NASDAQ:IMCR) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 902 thousand shares sold short, which is... 
Via Benzinga
News headline image
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash. 
Via Benzinga
News headline image
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday. 
Via Benzinga
News headline image
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
US Stocks Open Higher, Dow Surges 300 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. 
Via Benzinga
News headline image
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday ↗
  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗
Upgrades 
Via Benzinga
News headline image
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome ↗
Not all shares are slowing down alongside the industry group. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗
  
Via Benzinga
News headline image
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
News headline image
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗
  
Via Benzinga
News headline image
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday ↗
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.